Skip to main content
Premium Trial:

Request an Annual Quote

Blue Stream Buys Agilent's Mass Spec, HPLC Tools for Proteomics Services

NEW YORK (GenomeWeb News) — Blue Stream Laboratories has purchased a suite of Agilent Technologies’ proteomics products for its drug-development work, Agilent said today.
 
Boston-based Blue Stream has stocked its protein-characterization lab with Agilent's HPLC-chip and its 6210 time-of-flight mass spectrometer with MALDI and electrospray capabilities.
 
The deal also includes software and services that support the technology, Agilent said.
 
Blue Stream said its services includes analytical and in vitro biological method development, validation and testing, formulation support, and microbiological testing.
 
Financial terms of the agreement were not released.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.